Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice

doi:10.3748/wjg.v25.i11.1307

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (18506)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

2107

WORD

335

HTML

12261

Figures (1-1)

159

Tables (1-3)

189

Sum=15051

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

626

Download

665

Sum=1291

Publishing Process of This Article

Item

Count

Browse

1006

Download

1158

Sum=2164

Mar 21, 2019 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (146)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Mar 21, 2019; 25(11): 1307-1326
Published online Mar 21, 2019. doi: 10.3748/wjg.v25.i11.1307

Open in New Tab Full Size Figure Download Figure

Figure 1 Clinical algorithm with noninvasive testing and liver content measurement by Fibroscan for detecting advanced fibrosis in nonalcoholic fatty liver disease patients. NFS: Nonalcoholic fatty liver disease fibrosis score; NAFLD: Nonalcoholic fatty liver disease; NASH: Nonalcoholic fatty hepatitis; LSM: Liver stiffness measurement.

Citation: Zhou JH, Cai JJ, She ZG, Li HL. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice. World J Gastroenterol 2019; 25(11): 1307-1326
URL: https://www.wjgnet.com/1007-9327/full/v25/i11/1307.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i11.1307